In addition, previous studies have discovered that mTOR is a critical candidate molecule; it phosphorylates tau protein (Sun et al., 2014; Tramutola et al., 2015), and the inhibition of mTOR can ameliorate AD symptoms (Wang et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.